-
N-(5-((4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)carbamoyl)-2-methylphenyl)-5-(thiophen-2-yl)nicotinamide
-
BD6299621186206-79-099%
-
¥1894.050mg
-
4-Amino-N-((S)-1-(((S)-3-(4-chlorophenyl)-1-(((S)-1-((2-(5-methoxy-1H-indol-3-yl)ethyl)amino)-1-oxo-3-(pyridin-4-yl)propan-2-yl)amino)-1-oxopropan-2-yl)amino)-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropan-2-yl)butanamide
-
BD011022842034159-30-198%
-
¥20428.0250mg
-
4-Methyl-3-((1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-N-(3-(trifluoromethyl)phenyl)benzamide
-
BD408315940310-85-098%
-
¥1074.025mg
-
3,4,8,9-Tetrahydroxy-6H-benzo[c]chromen-6-one
-
BD01088635131086-98-197%
-
¥924.010mg
-
3-(7-Amino-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenol
-
BD00828162861249-77-695%
-
¥1901.05mg
-
EphA2 agonist 2
-
BD016157662169273-66-798%
-
¥
-
Targefrin
-
BD023053713031514-44-798%
-
¥
-
N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
-
BD335357781613-23-898%
-
¥502.02mg
-
AWL-II-38.3
-
BD014284001135205-94-598%
-
¥52611.0100mg
-
4-Methyl-3-((2-methyl-6-(pyridin-3-yl)-2H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-N-(3-(trifluoromethyl)phenyl)benzamide
-
BD011423812245892-85-599+%
-
¥2406.010mg
-
N-(2-Chlorophenyl)-6-(piperidin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide oxalate
-
BD011485871198408-78-497%
-
¥
-
EphA2 agonist 1
-
BD015968012611459-57-398%
-
¥
-
ALW-II-49-7
-
BD018485631135219-23-698%
-
¥
-
1-(1-((2-Aminopyridin-4-yl)methyl)-1H-indol-4-yl)-3-(5-bromo-2-methoxyphenyl)urea
-
BD630980900573-88-898+%
-
¥989.050mg
-
ML786 dihydrochloride
-
BD007985471237536-18-398%
-
¥2746.025mg
-
6-(3-methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine
-
BD00802624861249-59-495%
-
¥3671.0100mg